A simple selection system for construction of recombinant gD-negative pseudorabies virus as a vaccine vector.

[1]  A. Shiau,et al.  Prothymosin alpha enhances protective immune responses induced by oral DNA vaccination against pseudorabies delivered by Salmonella choleraesuis. , 2001, Vaccine.

[2]  C. Chu,et al.  Vaccination with the glycoprotein D gene of pseudorabies virus delivered by nonpathogenic Escherichia coli elicits protective immune responses. , 2001, Vaccine.

[3]  L. Enquist,et al.  A self-recombining bacterial artificial chromosome and its application for analysis of herpesvirus pathogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Inglis,et al.  An efficient selection system for packaging herpes simplex virus amplicons. , 1998, The Journal of general virology.

[5]  T. Kimman,et al.  Biologically safe, non-transmissible pseudorabies virus vector vaccine protects pigs against both Aujeszky's disease and classical swine fever. , 1997, The Journal of general virology.

[6]  R. Rouse,et al.  Rapid method for construction of recombinant HSV gene transfer vectors , 1997, Gene Therapy.

[7]  T. Mettenleiter,et al.  Green fluorescent protein expressed by recombinant pseudorabies virus as an in vivo marker for viral replication. , 1997, Journal of virological methods.

[8]  T. Kimman,et al.  Glycoprotein D-negative pseudorabies virus can spread transneuronally via direct neuron-to-neuron transmission in its natural host, the pig, but not after additional inactivation of gE or gI , 1996, Journal of virology.

[9]  T. Kimman,et al.  Role of viral proteins and concanavalin A in in vitro replication of pseudorabies virus in porcine peripheral blood mononuclear cells. , 1995, The Journal of general virology.

[10]  N. de Wind,et al.  Inactivation of glycoprotein gE and thymidine kinase or the US3-encoded protein kinase synergistically decreases in vivo replication of pseudorabies virus and the induction of protective immunity. , 1994, Virology.

[11]  T. Kimman,et al.  Glycoprotein gE-negative pseudorabies virus has a reduced capability to infect second- and third-order neurons of the olfactory and trigeminal routes in the porcine central nervous system. , 1994, The Journal of general virology.

[12]  B. Klupp,et al.  Characterization of a quadruple glycoprotein-deleted pseudorabies virus mutant for use as a biologically safe live virus vaccine. , 1994, The Journal of general virology.

[13]  T. Kimman,et al.  Non-transmissible pseudorabies virus gp50 mutants: a new generation of safe live vaccines. , 1994, Vaccine.

[14]  B. Klupp,et al.  Glycoprotein gp50-negative pseudorabies virus: a novel approach toward a nonspreading live herpesvirus vaccine , 1993, Journal of virology.

[15]  B. Peeters,et al.  Envelope glycoprotein gp50 of pseudorabies virus is essential for virus entry but is not required for viral spread in mice , 1993, Journal of virology.

[16]  P. Payment,et al.  Methods and techniques in virology , 1993 .

[17]  N. de Wind,et al.  Pseudorabies virus envelope glycoproteins gp50 and gII are essential for virus penetration, but only gII is involved in membrane fusion , 1992, Journal of virology.

[18]  T. Mettenleiter,et al.  Firefly luciferase as a marker for herpesvirus (pseudorabies virus) replication in vitro and in vivo. , 1991, The Journal of general virology.

[19]  T. Mettenleiter,et al.  Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration , 1991, Journal of virology.

[20]  N. de Wind,et al.  Linker insertion mutagenesis of herpesviruses: inactivation of single genes within the Us region of pseudorabies virus , 1990, Journal of virology.

[21]  T. Mettenleiter,et al.  A glycoprotein gX-beta-galactosidase fusion gene as insertional marker for rapid identification of pseudorabies virus mutants. , 1990, Journal of virological methods.

[22]  A. Gielkens,et al.  Inactivation of the thymidine kinase gene of a gI deletion mutant of pseudorabies virus generates a safe but still highly immunogenic vaccine strain. , 1990, The Journal of general virology.

[23]  H. Rziha,et al.  Development of an ELISA for detection of antibodies to glycoprotein I of Aujeszky's disease virus: a method for the serological differentiation between infected and vaccinated pigs. , 1988, Journal of virological methods.

[24]  S. Kit,et al.  Second-generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes. , 1987, American journal of veterinary research.

[25]  A. Kaplan,et al.  Vaccination of swine with thymidine kinase-deficient mutants of pseudorabies virus. , 1985, American journal of veterinary research.